Literature DB >> 21034823

Imperfect vaccine-induced immunity and whooping cough transmission to infants.

Jennie Lavine1, Hélène Broutin, Eric T Harvill, Ottar N Bjørnstad.   

Abstract

Whooping cough, caused by B. pertussis and B. parapertussis, has increased in incidence throughout much of the developed world since the 1980s despite high vaccine coverage, causing an increased risk of infection in infants who have substantial disease-induced mortality. Duration of immunity and epidemically significant routes of transmission across age groups remain unclear and deserve further investigation to inform vaccination strategies to better control pertussis burden. The authors analyze age- and species-specific whooping cough tests and vaccine histories in Massachusetts from 1990 to 2008. On average, the disease-free duration is 10.5 years. However, it has been decreasing over time, possibly due to a rising force of infection through increased circulation. Despite the importance of teenage cases during epidemics, wavelet analyses suggest that they are not the most important source of transmission to infants. In addition, the data indicate that the B. pertussis vaccine is not protective against disease induced by B. parapertussis.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034823      PMCID: PMC2997163          DOI: 10.1016/j.vaccine.2010.10.029

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Travelling waves and spatial hierarchies in measles epidemics.

Authors:  B T Grenfell; O N Bjørnstad; J Kappey
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

2.  Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains.

Authors:  E Mazengia; E A Silva; J A Peppe; R Timperi; H George
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  The science and fiction of the "resurgence" of pertussis.

Authors:  James D Cherry
Journal:  Pediatrics       Date:  2003-08       Impact factor: 7.124

4.  Loss of immunity to pertussis in a rural community in Senegal.

Authors:  Hélène Broutin; Pejman Rohani; Jean-François Guégan; Bryan T Grenfell; François Simondon
Journal:  Vaccine       Date:  2004-01-26       Impact factor: 3.641

5.  Laboratory-confirmed reinfections with Bordetella pertussis.

Authors:  F G A Versteegh; J F P Schellekens; A F Nagelkerke; J J Roord
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

6.  Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.

Authors:  M Watanabe; M Nagai
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.

Authors:  P Strebel; J Nordin; K Edwards; J Hunt; J Besser; S Burns; G Amundson; A Baughman; W Wattigney
Journal:  J Infect Dis       Date:  2001-03-30       Impact factor: 5.226

8.  Acellular pertussis vaccination facilitates Bordetella parapertussis infection in a rodent model of bordetellosis.

Authors:  Gráinne H Long; Alexia T Karanikas; Eric T Harvill; Andrew F Read; Peter J Hudson
Journal:  Proc Biol Sci       Date:  2010-03-03       Impact factor: 5.349

9.  The changing age and seasonal profile of pertussis in Canada.

Authors:  Danuta M Skowronski; Gaston De Serres; Diane MacDonald; Wrency Wu; Carol Shaw; Jane Macnabb; Sylvie Champagne; David M Patrick; Scott A Halperin
Journal:  J Infect Dis       Date:  2002-04-22       Impact factor: 5.226

10.  Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines.

Authors:  J G Liese; C Renner; S Stojanov; B H Belohradsky
Journal:  Arch Dis Child       Date:  2003-08       Impact factor: 3.791

View more
  25 in total

1.  Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure.

Authors:  Jennie S Lavine; Aaron A King; Ottar N Bjørnstad
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

2.  Boosting understanding of pertussis outbreaks.

Authors:  Bryan Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-20       Impact factor: 11.205

Review 3.  Licensed pertussis vaccines in the United States. History and current state.

Authors:  Nicola P Klein
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

4.  Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine.

Authors:  Maja Jahnmatz; Margaretha Ljungman; Eva Netterlid; Maria C Jenmalm; Lennart Nilsson; Rigmor Thorstensson
Journal:  Clin Vaccine Immunol       Date:  2014-07-09

5.  Different effects of whole-cell and acellular vaccines on Bordetella transmission.

Authors:  William E Smallridge; Olivier Y Rolin; Nathan T Jacobs; Eric T Harvill
Journal:  J Infect Dis       Date:  2014-01-16       Impact factor: 5.226

6.  Bordetella parapertussis survives inside human macrophages in lipid raft-enriched phagosomes.

Authors:  Juan Gorgojo; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

7.  Bordetella parapertussis survives the innate interaction with human neutrophils by impairing bactericidal trafficking inside the cell through a lipid raft-dependent mechanism mediated by the lipopolysaccharide O antigen.

Authors:  Juan Gorgojo; Yanina Lamberti; Hugo Valdez; Eric T Harvill; Maria Eugenia Rodríguez
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

8.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

Review 9.  Resolving pertussis immunity and vaccine effectiveness using incidence time series.

Authors:  Jennie S Lavine; Pejman Rohani
Journal:  Expert Rev Vaccines       Date:  2012-11       Impact factor: 5.217

Review 10.  Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.

Authors:  Varun K Phadke; Robert A Bednarczyk; Daniel A Salmon; Saad B Omer
Journal:  JAMA       Date:  2016-03-15       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.